Utah Gastroenterology

CLIA Laboratory Citation Details

2
Total Citations
10
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 46D2080109
Address 6360 S 3000 E Suite 310, Salt Lake City, UT, 84121
City Salt Lake City
State UT
Zip Code84121
Phone(801) 944-3144

Citation History (2 surveys)

Survey - September 23, 2020

Survey Type: Standard

Survey Event ID: OF8H11

Deficiency Tags: D5445 D5445

Summary:

Summary Statement of Deficiencies D5445 CONTROL PROCEDURES CFR(s): 493.1256(d)(1)(2)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- (d)(1) Perform control procedures as defined in this section unless otherwise specified in the additional specialty and subspecialty requirements at 493.1261 through 493.1278. (d)(2) For each test system, perform control procedures using the number and frequency specified by the manufacturer or established by the laboratory when they meet or exceed the requirements in paragraph (d)(3) of this section. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on quality control records review, manufacturer's package insert review, lack of documentation, IQCP review, and interview with staff, the laboratory Individualized Quality Control Plan (IQCP) failed to include the number of controls the lab is to perform monthly and with each new lot number of Biofire Gastroenterology test kits received. Quality control review included testing from September 2018 to September 2020. The laboratory performed approximately 3 to 5 tests per week. Findings include: 1. Quality control records review failed to include documentation the laboratory performed a negative control with each new lot number of test kits received and monthly for 24 months of tests reviewed (September 2018 to September 2020). 2. Manufacturer's package insert stated good laboratory practice should include control materials that include the presence and absence of bacteria, fungi, parasites, and viruses with each new lot number of test kits received. 3. The IQCP review failed to include the number and type of quality controls to be performed with each new test kit lot number received and monthly. 4. In an interview with staff on 09/23/2020 at approximately 10:45 A.M. testing staff confirmed they did not perform a negative control since it was not included in the number of control required in the IQCP Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 26, 2018

Survey Type: Standard

Survey Event ID: 3N0311

Deficiency Tags: D2000 D5407 D5449 D5805 D2000 D5407 D5449 D5805

Summary:

Summary Statement of Deficiencies D2000 ENROLLMENT AND TESTING OF SAMPLES CFR(s): 493.801 Each laboratory must enroll in a proficiency testing (PT) program that meets the criteria in subpart I of this part and is approved by HHS. The laboratory must enroll in an approved program or programs for each of the specialties and subspecialties for which it seeks certification. The laboratory must test the samples in the same manner as patients' specimens. For laboratories subject to 42 CFR part 493 published on March 14, 1990 (55 FR 9538) prior to September 1, 1992, the rules of this subpart are effective on September 1, 1992. For all other laboratories, the rules of this subpart are effective January 1, 1994. This CONDITION is not met as evidenced by: Based on lack of documentation and confirmation by staff, the laboratory failed to enroll in an approved proficiency testing program for the sub specialties of Bacteriology, Parasitology and Virology for molecular stool sample testing for the presence or absence of approximately 21 Bacteriology, Parasitology and Virology organisms. The laboratory performed approximately 10 to 40 tests per month since April 2018 when patient testing began. D5407 PROCEDURE MANUAL CFR(s): 493.1251(d) Procedures and changes in procedures must be approved, signed, and dated by the current laboratory director before use. This STANDARD is not met as evidenced by: Based on procedure manual review, lack of documentation, and interview with staff, the laboratory director failed to sign and date as approved 1 of 1 new test procedure Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- added in April of 2018, Molecular detection for presence or absence of stool pathogens. The laboratory performed approximately 10 to 40 tests per month. Findings include: 1. Procedure manual review failed to include the signature and date the director approved the Biofire enteric pathogen test procedure. 2. In an interview on 07/26/2018 at approximately 4:00 P.M. staff stated the laboratory technical supervisor approved the procedure. D5449 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(ii)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Each qualitative procedure, include a negative and positive control material; (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on lack of the director's approval, quality control documentation review, and confirmation by laboratory staff, the laboratory failed to have an approved Individualized Quality Control Plan (IQCP) or perform 2 levels of quality control each day of stool pathogen testing by molecular amplification for approximately 10 to 20 days of testing. The laboratory performed approximately 1 to 2 tests per day. Findings include: 1. The IQCP reviewed was not approved by the laboratory director. 2. Quality control documentation review included monthly and new lot number quality control performance since April of 2018 when the laboratory started testing and reporting patient tests. 3. In an interview conducted on 07/26/2018 at approximately 4:00 P.M. staff confirmed the technical supervisor approved the IQCP. D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on patient testing observed, patient test report observed and interview with staff, the test report for the presence or absence of approximately 21 Bacteriology, Parasitology and Virology organisms, failed to include the name and address of the laboratory location where the tests are performed for approximately 60 of 60 tests performed from April 2018 to July 26, 2018. Findings include: 1. Patient testing observed on 07/6/2018 at approximately 5:10 P.M. did not include the name and address of the location where testing was performed. 2. In an interview conducted on 07/26/2018 at approximately 5:10 P.M. staff confirmed the test reports for stool pathogen testing did not include the location of the laboratory performing the tests. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access